Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.

Masonou T, Hokey DA, Lahey T, Halliday A, Berrocal-Almanza LC, Wieland-Alter WF, Arbeit RD, Lalvani A, von Reyn CF.

PLoS One. 2019 May 23;14(5):e0217091. doi: 10.1371/journal.pone.0217091. eCollection 2019.

2.

Herpes zoster as a cause of atypical chronic ulcerations associated with tofacitinib.

Noell C, Arbeit R, Kanhoush R.

Dermatol Online J. 2018 Jan 15;24(1). pii: 13030/qt3v77g2zg.

3.

Genetic correlates of clarithromycin susceptibility among isolates of the Mycobacterium abscessus group and the potential clinical applicability of a PCR-based analysis of erm(41).

Carvalho NFG, Pavan F, Sato DN, Leite CQF, Arbeit RD, Chimara E.

J Antimicrob Chemother. 2018 Apr 1;73(4):862-866. doi: 10.1093/jac/dkx476.

PMID:
29272470
4.

Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.

von Reyn CF, Lahey T, Arbeit RD, Landry B, Kailani L, Adams LV, Haynes BC, Mackenzie T, Wieland-Alter W, Connor RI, Tvaroha S, Hokey DA, Ginsberg AM, Waddell R.

PLoS One. 2017 May 12;12(5):e0175215. doi: 10.1371/journal.pone.0175215. eCollection 2017.

5.

Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.

Lahey T, Laddy D, Hill K, Schaeffer J, Hogg A, Keeble J, Dagg B, Ho MM, Arbeit RD, von Reyn CF.

PLoS One. 2016 Dec 20;11(12):e0168521. doi: 10.1371/journal.pone.0168521. eCollection 2016.

6.

IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.

Balak DM, van Doorn MB, Arbeit RD, Rijneveld R, Klaassen E, Sullivan T, Brevard J, Thio HB, Prens EP, Burggraaf J, Rissmann R.

Clin Immunol. 2017 Jan;174:63-72. doi: 10.1016/j.clim.2016.09.015. Epub 2016 Nov 20.

PMID:
27876460
7.

Isolation of Mycobacterium avium from Potable Water in Homes and Institutions of Patients with HIV Infection in Finland and the United States.

Ristola M, Arbeit RD, von Reyn CF, Horsburgh CR Jr.

Biomed Res Int. 2015;2015:713845. doi: 10.1155/2015/713845. Epub 2015 Jun 9.

8.

Suppression of molecular inflammatory pathways by Toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation.

Suárez-Fariñas M, Arbeit R, Jiang W, Ortenzio FS, Sullivan T, Krueger JG.

PLoS One. 2013 Dec 27;8(12):e84634. doi: 10.1371/journal.pone.0084634. eCollection 2013.

9.

Campylobacteriosis in urban versus rural areas: a case-case study integrated with molecular typing to validate risk factors and to attribute sources of infection.

Lévesque S, Fournier E, Carrier N, Frost E, Arbeit RD, Michaud S.

PLoS One. 2013 Dec 26;8(12):e83731. doi: 10.1371/journal.pone.0083731. eCollection 2013.

10.

Greater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis.

Lahey T, Czechura T, Crabtree S, Arbeit RD, Matee M, Horsburgh CR, MacKenzie T, Bakari M, Pallangyo K, von Reyn CF.

J Infect Dis. 2013 Nov 15;208(10):1629-33. doi: 10.1093/infdis/jit396. Epub 2013 Aug 1.

11.

Safety of zoster vaccine in elderly adults following documented herpes zoster.

Morrison VA, Oxman MN, Levin MJ, Schmader KE, Guatelli JC, Betts RF, Gelb LD, Pachucki CT, Keay SK, Menzies B, Griffin MR, Kauffman CA, Marques AR, Toney JF, Simberkoff MS, Serrao R, Arbeit RD, Gnann JW, Greenberg RN, Holodniy M, Keitel WA, Yeh SS, Davis LE, Crawford GE, Neuzil KM, Johnson GR, Zhang JH, Harbecke R, Chan IS, Keller PM, Williams HM, Boardman KD, Silber JL, Annunziato PW; Shingles Prevention Study Group.

J Infect Dis. 2013 Aug 15;208(4):559-63. doi: 10.1093/infdis/jit182. Epub 2013 Apr 30.

12.

Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania.

Kabali C, Mtei L, Brooks DR, Waddell R, Bakari M, Matee M, Arbeit RD, Pallangyo K, von Reyn CF, Horsburgh CR.

Tuberculosis (Edinb). 2013 Jul;93(4):461-6. doi: 10.1016/j.tube.2013.01.001. Epub 2013 Mar 22.

13.

Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis.

Lahey T, Mackenzie T, Arbeit RD, Bakari M, Mtei L, Matee M, Maro I, Horsburgh CR, Pallangyo K, von Reyn CF.

Clin Infect Dis. 2013 Jan;56(1):151-8. doi: 10.1093/cid/cis798. Epub 2012 Sep 12.

14.

A randomized, evaluator-blind, phase 2 study comparing the safety and efficacy of omadacycline to those of linezolid for treatment of complicated skin and skin structure infections.

Noel GJ, Draper MP, Hait H, Tanaka SK, Arbeit RD.

Antimicrob Agents Chemother. 2012 Nov;56(11):5650-4. doi: 10.1128/AAC.00948-12. Epub 2012 Aug 20.

15.

Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal disease.

Adams LV, Kreiswirth BN, Arbeit RD, Soini H, Mtei L, Matee M, Bakari M, Lahey T, Wieland-Alter W, Shashkina E, Kurepina N, Driscoll JR, Pallangyo K, Horsburgh CR, von Reyn CF.

J Clin Microbiol. 2012 Aug;50(8):2645-50. doi: 10.1128/JCM.00624-12. Epub 2012 May 30.

16.

New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.

von Reyn CF, Bakari M, Arbeit RD, Lahey T, Ramadhani A, Egwaga S.

Int J Tuberc Lung Dis. 2012 Jun;16(6):718-23. doi: 10.5588/ijtld.11.0444. Epub 2012 Apr 9. Review.

PMID:
22507085
17.

Use of amplified-fragment length polymorphism to study the ecology of Campylobacter jejuni in environmental water and to predict multilocus sequence typing clonal complexes.

Lévesque S, St-Pierre K, Frost E, Arbeit RD, Michaud S.

Appl Environ Microbiol. 2012 Apr;78(7):2470-3. doi: 10.1128/AEM.06527-11. Epub 2012 Jan 20.

18.

Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.

Kabali C, von Reyn CF, Brooks DR, Waddell R, Mtei L, Bakari M, Matee M, Pallangyo K, Arbeit RD, Horsburgh CR Jr.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1515-21, i. doi: 10.5588/ijtld.10.0788.

PMID:
22008766
19.

Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.

Lahey T, Mitchell BK, Arbeit RD, Sheth S, Matee M, Horsburgh CR, MacKenzie T, Mtei L, Bakari M, Vuola JM, Pallangyo K, von Reyn CF.

PLoS One. 2011;6(7):e22074. doi: 10.1371/journal.pone.0022074. Epub 2011 Jul 20.

20.

Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality.

von Reyn CF, Kimambo S, Mtei L, Arbeit RD, Maro I, Bakari M, Matee M, Lahey T, Adams LV, Black W, Mackenzie T, Lyimo J, Tvaroha S, Waddell R, Kreiswirth B, Horsburgh CR, Pallangyo K.

Int J Tuberc Lung Dis. 2011 Aug;15(8):1087-92. doi: 10.5588/ijtld.10.0517.

PMID:
21740673
21.

Determination of the optimal culture conditions for detecting thermophilic campylobacters in environmental water.

Lévesque S, St-Pierre K, Frost E, Arbeit RD, Michaud S.

J Microbiol Methods. 2011 Jul;86(1):82-8. doi: 10.1016/j.mimet.2011.04.001. Epub 2011 Apr 12.

PMID:
21504767
22.

High-resolution melting system to perform multilocus sequence typing of Campylobacter jejuni.

Lévesque S, Michaud S, Arbeit RD, Frost EH.

PLoS One. 2011 Jan 24;6(1):e16167. doi: 10.1371/journal.pone.0016167.

23.

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.

Lahey T, Arbeit RD, Bakari M, Horsburgh CR, Matee M, Waddell R, Mtei L, Vuola JM, Pallangyo K, von Reyn CF.

Vaccine. 2010 Nov 10;28(48):7652-8. doi: 10.1016/j.vaccine.2010.09.041. Epub 2010 Sep 25.

24.

Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.

Lahey T, Sheth S, Matee M, Arbeit R, Horsburgh CR, Mtei L, Mackenzie T, Bakari M, Vuola JM, Pallangyo K, von Reyn CF.

J Infect Dis. 2010 Oct 15;202(8):1265-72. doi: 10.1086/656332.

25.

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.

Simberkoff MS, Arbeit RD, Johnson GR, Oxman MN, Boardman KD, Williams HM, Levin MJ, Schmader KE, Gelb LD, Keay S, Neuzil K, Greenberg RN, Griffin MR, Davis LE, Morrison VA, Annunziato PW; Shingles Prevention Study Group.

Ann Intern Med. 2010 May 4;152(9):545-54. doi: 10.7326/0003-4819-152-9-201005040-00004.

PMID:
20439572
26.

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.

von Reyn CF, Mtei L, Arbeit RD, Waddell R, Cole B, Mackenzie T, Matee M, Bakari M, Tvaroha S, Adams LV, Horsburgh CR, Pallangyo K; DarDar Study Group.

AIDS. 2010 Mar 13;24(5):675-85. doi: 10.1097/QAD.0b013e3283350f1b.

PMID:
20118767
27.

Thermotolerant coliforms are not a good surrogate for Campylobacter spp. in environmental water.

St-Pierre K, Lévesque S, Frost E, Carrier N, Arbeit RD, Michaud S.

Appl Environ Microbiol. 2009 Nov;75(21):6736-44. doi: 10.1128/AEM.00486-09. Epub 2009 Sep 4.

28.

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Schödel F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ; US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators.

J Infect Dis. 2009 Oct 1;200(7):1068-77. doi: 10.1086/605611.

29.

A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses.

Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM; Shingles Prevention Study Group.

J Med Virol. 2009 Jul;81(7):1310-22. doi: 10.1002/jmv.21506.

30.

Multilocus sequence typing of Campylobacter jejuni isolates from humans, chickens, raw milk, and environmental water in Quebec, Canada.

Lévesque S, Frost E, Arbeit RD, Michaud S.

J Clin Microbiol. 2008 Oct;46(10):3404-11. doi: 10.1128/JCM.00042-08. Epub 2008 Aug 13.

31.

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.

Pertel PE, Bernardo P, Fogarty C, Matthews P, Northland R, Benvenuto M, Thorne GM, Luperchio SA, Arbeit RD, Alder J.

Clin Infect Dis. 2008 Apr 15;46(8):1142-51. doi: 10.1086/533441.

PMID:
18444848
32.
33.

Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture.

Bakari M, Arbeit RD, Mtei L, Lyimo J, Waddell R, Matee M, Cole BF, Tvaroha S, Horsburgh CR, Soini H, Pallangyo K, von Reyn CF.

BMC Infect Dis. 2008 Mar 6;8:32. doi: 10.1186/1471-2334-8-32.

34.

Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.

Matee M, Lahey T, Vuola JM, Mtei L, Cole BF, Bakari M, Arbeit RD, Horsburgh CR, Pallangyo K, von Reyn CF.

J Infect Dis. 2007 Jan 1;195(1):118-23. Epub 2006 Nov 20.

35.

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group.

N Engl J Med. 2005 Jun 2;352(22):2271-84.

37.

Identification of a novel peptidoglycan hydrolase CwlM in Mycobacterium tuberculosis.

Deng LL, Humphries DE, Arbeit RD, Carlton LE, Smole SC, Carroll JD.

Biochim Biophys Acta. 2005 Feb 14;1747(1):57-66. Epub 2004 Nov 11.

PMID:
15680239
38.

Campylobacteriosis, Eastern Townships, Quebec.

Michaud S, Ménard S, Arbeit RD.

Emerg Infect Dis. 2004 Oct;10(10):1844-7.

39.

Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.

Fowler VG Jr, Sakoulas G, McIntyre LM, Meka VG, Arbeit RD, Cabell CH, Stryjewski ME, Eliopoulos GM, Reller LB, Corey GR, Jones T, Lucindo N, Yeaman MR, Bayer AS.

J Infect Dis. 2004 Sep 15;190(6):1140-9. Epub 2004 Aug 12.

PMID:
15319865
40.

Population pharmacokinetics of daptomycin.

Dvorchik B, Arbeit RD, Chung J, Liu S, Knebel W, Kastrissios H.

Antimicrob Agents Chemother. 2004 Aug;48(8):2799-807.

41.

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.

Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI; Daptomycin 98-01 and 99-01 Investigators.

Clin Infect Dis. 2004 Jun 15;38(12):1673-81. Epub 2004 May 20.

PMID:
15227611
42.

Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.

Vuola JM, Ristola MA, Cole B, Järviluoma A, Tvaroha S, Rönkkö T, Rautio O, Arbeit RD, von Reyn CF.

AIDS. 2003 Nov 7;17(16):2351-5.

PMID:
14571187
43.

Disseminated Mycobacterium genavense in an HIV-infected patient from South America.

Hadad DJ, Smole SC, Martins CC, Erica C, Ueki SY, Palhares MC, Arbeit RD, Pignatari AC.

Int J Tuberc Lung Dis. 2003 May;7(5):502-3. No abstract available. Erratum in: Int J Tuberc Lung Dis. 2003 Sep;7(9):910.

PMID:
12757055
44.

Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.

Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD.

Antimicrob Agents Chemother. 2003 Apr;47(4):1318-23.

45.

Clinical and epidemiological correlates of genotypes within the Mycobacterium avium complex defined by restriction and sequence analysis of hsp65.

Smole SC, McAleese F, Ngampasutadol J, Von Reyn CF, Arbeit RD.

J Clin Microbiol. 2002 Sep;40(9):3374-80.

46.

Sources of disseminated Mycobacterium avium infection in AIDS.

von Reyn CF, Arbeit RD, Horsburgh CR, Ristola MA, Waddell RD, Tvaroha SM, Samore M, Hirschhorn LR, Lumio J, Lein AD, Grove MR, Tosteson AN.

J Infect. 2002 Apr;44(3):166-70.

PMID:
12099743
47.

Sample preparation of Gram-positive bacteria for identification by matrix assisted laser desorption/ionization time-of-flight.

Smole SC, King LA, Leopold PE, Arbeit RD.

J Microbiol Methods. 2002 Feb;48(2-3):107-15.

PMID:
11777561
48.

Comparison of SmaI-defined genotypes of Campylobacter jejuni examined by KpnI: a population-based study.

Michaud S, Menard S, Gaudreau C, Arbeit RD.

J Med Microbiol. 2001 Dec;50(12):1075-81.

PMID:
11761192
49.

Dealing with variation in molecular typing of Mycobacterium tuberculosis: low-intensity bands and other challenges.

van Soolingen D, Arbeit RD.

J Med Microbiol. 2001 Sep;50(9):749-51. No abstract available.

PMID:
11549175
50.

Molecular strain typing of Campylobacter jejuni by pulsed-field gel electrophoresis in a single day.

Michaud S, Arbeit RD, Gaudreau C.

Can J Microbiol. 2001 Jul;47(7):667-9.

PMID:
11547887

Supplemental Content

Loading ...
Support Center